One of the highest paid multinational company, the prestigious title with lots of responsibilities – these are the ultimate symbols of corporate success. But it
Dr. Reddy’s Laboratories Chairman Satish Reddy has cautioned that India should not accept ‘regulatory data protection’ terms just to attract foreign investment. He warned this
The revised draft National Pharmacy Commission (NPC) Bill, 2026, which aims to set up the National Pharmacy Commission (NPC) and repealing the Pharmacy Act, 1948,
The United States Food and Drug Administration (USFDA) has reached out to Indian pharmaceutical manufacturers through the Indian Drug Manufacturers’ Association (IDMA) for help in
Amid concerns over the illegal entry of unapproved and unlicensed medicines into India, the country’s apex drug regulatory agency has directed all state and Union
India’s USD 30.5-billion pharmaceutical export industry, which supplies medicines to more than 200 countries, could soon see tighter oversight of one of its least regulated
For someone with a dangerous tumor, surgical removal of the cancer may bring immediate relief but leave the person with an uncertain future. Sometimes, remnant
Industry associations have urged the government to make effective use of the substantial unutilised capacity available with domestic Active Pharmaceutical Ingredient (API) manufacturers. This, according